Latest Innovation News

AdAlta, Oribiotech, and Cell Therapies have inked a Memorandum of Understanding to deploy Oribiotech’s IRO automated cell therapy manufacturing platform in Australia and Asia Pacific, aiming to slash costs and boost production speed for CAR-T therapies.

dorsaVi has confirmed that its proprietary RRAM memory technology and neuromorphic IP portfolio work seamlessly together, projecting a tenfold boost in performance for robotics and exoskeleton applications. This breakthrough lays the groundwork for smarter, faster, and more energy-efficient wearable and robotic devices operating at the ultra-edge.

Xenitra Limited has swiftly moved from concept to commercial traction, generating over $100,000 in sales within the first week of launching EZZ Life Sciences products on its blockchain-based OPAL token ecosystem.

Hiremii Limited has delivered its most profitable quarter yet, reporting record revenue and gross profit alongside its first positive adjusted EBITDA. The company also secured its first recurring SaaS contracts, marking a milestone in its shift towards a technology-driven workforce intelligence model.

Cleanaway Waste Management has refreshed its long-term strategy, Blueprint 2030 2.0, focusing on leveraging scale, digitisation, and targeted growth to boost margins and cash flow. The plan builds on solid FY25 financial gains and aims for sustained EPS growth and operational efficiency.

HUB24 continued its strong growth trajectory in Q3 FY26 with $4 billion in net platform inflows and announced plans to acquire the trustee of its super fund, signaling strategic consolidation amid market volatility.

AnteoTech (ASX: ADO) pushed forward its advanced battery and life sciences technologies in the March 2026 quarter, achieving key product validations and expanding its sales pipeline to record levels. The company ended the period with A$3.3 million cash and no debt following a recent A$3.5 million capital raise.

MyEco Group has locked in $0.92 million through its Series 2 convertible note program, reinforcing its growth trajectory with funding earmarked for a new GRS-certified recycled bin liner range. The raise supplements a solid cash position while aiming to limit shareholder dilution amid challenging market conditions.

Emyria has unveiled the Empax Global Partnership Program, a high-margin clinical delivery platform targeting international drug sponsors amid growing demand for psychedelic-assisted mental health treatments.

ION Video has trimmed its monthly cash burn to $148,000, beating management’s forecast, and expects to maintain sufficient funding until at least mid-2027. Meanwhile, early-stage discussions with tech giants Meta and Alphabet remain active but non-binding.

Radiopharm Theranostics has reported encouraging initial results from the Phase 1 HEAT trial of its novel HER2-targeted radiopharmaceutical, 177Lu-RAD202, highlighting tumor uptake and a clean safety profile at the lowest dose with dose escalation approved.

Talius Group has reported its second consecutive quarter of positive operating cash flow, alongside an 11% annual increase in subscriptions and a $1.81 million revenue haul for Q1 FY26. The appointment of Pat Howard as CEO and a new $567k contract with Seventh-Day Adventist Aged Care signal momentum in the company’s push toward scalable growth.